Daniel J. Haraf to Organoplatinum Compounds
This is a "connection" page, showing publications Daniel J. Haraf has written about Organoplatinum Compounds.
Connection Strength
0.063
-
A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest. Invest New Drugs. 2001; 19(4):303-10.
Score: 0.048
-
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83.
Score: 0.016